Vimarsana
Biggest News Aggregation in the World

Page 6 - Weight Management Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Weight Management Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Weight Management Program Today - Breaking & Trending Today

Army Veteran loses over 50 pounds with Hines VA's MOVE! Weight Management Program - Vimarsana News

Army Veteran loses over 50 pounds with Hines VA's MOVE! Weight Management Program

Approximately 80% of Veterans are overweight or obese, according to the Department of Veterans Affairs. Donald Logan was one of them. Following a hospitalization for diabetes in July 2023, the Army Ve...

Ozempic Overdose: What Happens When You Take Too Much? - Vimarsana News

Ozempic Overdose: What Happens When You Take Too Much?

Last year, 3,316 semaglutide overdoses were reported by 55 poison control centers in the U.S. Compounded versions, which can contain semaglutide salts, are likely behind most of the overdoses.

Source: health.com
ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, ... - Vimarsana News

ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, ...

IRVINE, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that bariatric surgical fellows from

Why the future for Americans with obesity is looking brighter in 2024 - Vimarsana News

Why the future for Americans with obesity is looking brighter in 2024

Doctors hope FDA approval of a pill for postpartum depression called Zuranolone (under the brand name Zurzuvae) could raise awareness and increase treatment options for this debilitating condition.

Source: ksl.com
FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro - Vimarsana News

FDA Approves New Diet Drug Zepbound, a Version of the Diabetes Med Mounjaro

The U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity. Tirzepatide, the active ingredient in Zepbound, is already approved under the trade name Mounjaro to be used along with diet and exercise to help improve blood sugar in adults with type 2 diabetes mellitus.